Let's CombinateL Drugs + Devices

Episodes

171 - Are Pre-Filled Syringes with Vaccines, Biologics, Generics, or Small Molecules considered Combination Products?

171 - Are Pre-Filled Syringes with Vaccines, Biologics, Generics, or Small Molecules considered Combination Products?

Episode page
The #1 Secret to Understanding ISO 13485 (You’ll Wish You Knew Sooner)

The #1 Secret to Understanding ISO 13485 (You’ll Wish You Knew Sooner)

Episode page
169 - Should You Study Bioengineering in 2025? My Decade-Long Perspective

169 - Should You Study Bioengineering in 2025? My Decade-Long Perspective

Episode page
168 - Audits, Audits, Audits: Why They Matter in Pharma, Medical Devices, and Personal Growth

168 - Audits, Audits, Audits: Why They Matter in Pharma, Medical Devices, and Personal Growth

Episode page
167 - Smart Pills, Digital Drug Delivery Systems, and How Technology is Reshaping Pharma and Healthcare with Timothy Aungst

167 - Smart Pills, Digital Drug Delivery Systems, and How Technology is Reshaping Pharma and Healthcare with Timothy Aungst

Episode page
Sync or Sink: 3 Levels of Harmonization for Combination Product Success

Sync or Sink: 3 Levels of Harmonization for Combination Product Success

Episode page
165 - Anatomy of a Target Product Profile(TPP): All 10 Sections EXPLAINED with Marta New

165 - Anatomy of a Target Product Profile(TPP): All 10 Sections EXPLAINED with Marta New

Episode page
164 - Tiny Particles, Big Impact: Breaking down USP 788 & USP 790

164 - Tiny Particles, Big Impact: Breaking down USP 788 & USP 790

Episode page
163 - ICH Q12, Established Conditions, Post-Approval Changes, PACMP's, and the Pharma Lifecycle

163 - ICH Q12, Established Conditions, Post-Approval Changes, PACMP's, and the Pharma Lifecycle

Episode page
162 - Philip Crosby’s 5 Bad Beliefs About Quality (And How to Avoid Them)

162 - Philip Crosby’s 5 Bad Beliefs About Quality (And How to Avoid Them)

Episode page
161 - ISO 14971 and ICH Q9 EXPLAINED: Risk Management Frameworks in Medical Devices, Pharma and Combination Products

161 - ISO 14971 and ICH Q9 EXPLAINED: Risk Management Frameworks in Medical Devices, Pharma and Combination Products

Episode page
160 - Drug Tech Transfer vs. Device Design Transfer EXPLAINED!

160 - Drug Tech Transfer vs. Device Design Transfer EXPLAINED!

Episode page
159 - Centralized, Decentralized & Federated Quality Models, McKinsey Study, and QA vs. QC with Ben Locwin

159 - Centralized, Decentralized & Federated Quality Models, McKinsey Study, and QA vs. QC with Ben Locwin

Episode page
158 - 3 Years Straight of Drug/Device Podcasting, Guarding the Process, and the Future of the Show

158 - 3 Years Straight of Drug/Device Podcasting, Guarding the Process, and the Future of the Show

Episode page
157 - Design Inputs that Don't Suck, Risk Control Measures and Problems with Verification with Chuck Ventura

157 - Design Inputs that Don't Suck, Risk Control Measures and Problems with Verification with Chuck Ventura

Episode page
156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar

156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar

Episode page
155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach

155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach

Episode page
154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell

154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell

Episode page
153 - USP 382, Elastomeric Component Functional Suitability, Delivery Systems, Spikes, IV Bags and Alternate Packaging with Fran Degrazio

153 - USP 382, Elastomeric Component Functional Suitability, Delivery Systems, Spikes, IV Bags and Alternate Packaging with Fran Degrazio

Episode page
152 - Global Medical Device Podcast Interview: Behind the Combinate Podcast, Combination Products Why, Unique Episodes, Pyramids and Books with Etienne Nichols & Subhi Saadeh

152 - Global Medical Device Podcast Interview: Behind the Combinate Podcast, Combination Products Why, Unique Episodes, Pyramids and Books with Etienne Nichols & Subhi Saadeh

Episode page
151 - Primary Packaging/Container Closure Change Guidance, Post-Approval Changes, Sponsor/Supplier Relationships, Purchasing Controls and Tubular vs. Molded Glass with Fran Degrazio

151 - Primary Packaging/Container Closure Change Guidance, Post-Approval Changes, Sponsor/Supplier Relationships, Purchasing Controls and Tubular vs. Molded Glass with Fran Degrazio

Episode page
150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar

150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar

Episode page
149 - Lyophilization/Freeze-Drying Equipment, Environment, Cleaning, Loading, Automation, Refrigeration, Vacuum, Filtration, and Potent/Non-Aqueous Considerationswith David

149 - Lyophilization/Freeze-Drying Equipment, Environment, Cleaning, Loading, Automation, Refrigeration, Vacuum, Filtration, and Potent/Non-Aqueous Considerationswith David

Episode page
148 - Standards Applicability Assessments, Atomic Requirements, Documentation and Timing with Leo Eisner

148 - Standards Applicability Assessments, Atomic Requirements, Documentation and Timing with Leo Eisner

Episode page